{
  "docId": "019dd923-5e88-73ef-bd5c-f6fdd8f57895",
  "docSlug": "3a892393f72c1ff5",
  "documentTitle": "2019 Air Street Capital The State of AI Report 2019",
  "authorId": "AirStreetCapital",
  "authorName": "Nathan Benaich and Ian Hogarth",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 82,
  "pageCount": 136,
  "prevPage": 81,
  "nextPage": 83,
  "slideType": "client_example",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide highlights the trend of AI-driven drug discovery through specific industry examples.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "logo_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5c-f6fdd8f57895/82",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5c-f6fdd8f57895",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5c-f6fdd8f57895.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5c-f6fdd8f57895#slide-82",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "image",
      "text": "insitro + Gilead",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ab98326-6f5b-4167-a1db-b42a87da5409",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.05,
        "y": 0.21
      },
      "kind": "image",
      "text": "LabGenius + Tillotts Pharma",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ede6842f-690c-41b3-9558-0802daf8209b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Insitro, an SF-based startup, launched with $100M in VC financing and announced a three-year collaboration with Gilead. The deal is to create disease models for nonalcoholic steatohepatitis (NASH), a chronic form of liver disease with limited treatment options and that can result in cancer. insitro will receive an upfront payment of $15M, with additional near-term payments up to $35M based on operational milestones. insitro will be eligible to receive up to $200M for the achievement of preclinical, development, regulatory and commercial milestones for each of the five potential Gilead targets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "002375f8-ad23-45d6-8240-88bd557e9633",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "LabGenius, a London-based startup, uses AI-driven evolution strategies to develop radically improved protein therapeutics. They have entered into a discovery agreement with Tillotts Pharma to identify and develop new drug candidates for the treatment of inflammatory bowel diseases (IBD), such as Crohn’s disease. The two-year long collaboration sees LabGenius generate molecules that, together with Tillotts, will be filtered into lead candidates for future development and commercialisation by Tillotts.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fcaabbbe-328b-4de4-a924-39f2e6322fef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.85,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "stateof.ai 2019",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "449b408c-d468-4e95-a232-021717246aee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "Healthcare: Pharma companies partner with AI-driven drug development companies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e433338-202f-4c01-b708-e1c9ea5f11e5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 92,
      "from": 5,
      "beatId": "019dd95a-0682-776c-8e34-ce57e5bbe574",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Definitions through Research/Talent/Industry — fact-dense case studies and benchmarks.",
      "position": 1,
      "confidence": 70,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 92,
      "from": 9,
      "beatId": "019dd95a-0682-776c-8e34-ddbccb391af1",
      "arcName": "Voyage and Return",
      "arcSlug": "voyage-return",
      "beatName": "The Unknown",
      "beatSlug": "voyage-return-the-unknown",
      "evidence": "Research/Talent/Industry frontiers explored.",
      "position": 2,
      "confidence": 45,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 83,
      "from": 80,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3c-cc75c4a0b6da",
      "evidence": "FDA clearances, Atomwise $2.4B deals, nutrition prediction case studies.",
      "position": 15,
      "objective": "Stack healthcare/pharma AI deployment evidence",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 70,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}